|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| MDS | |||||
| Anemia, Aplastic | |||||
| Inborn Errors of Metabolism | |||||
| Congenital Marrow Failure | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Immunologic Deficiency Syndromes | |||||
| Metabolism, Inborn Errors | |||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Anemia | |||||
| Bone Marrow Diseases | |||||
| Disease | |||||
| Genetic Diseases, Inborn | |||||
| Hematologic Diseases | |||||
| Immune System Diseases | |||||
| Metabolic Diseases | |||||
| Pathologic Processes | |||||
| 4 | Interventions listed in this trial | ||||
| ALDHbr Umbilical Cord Blood Cells | |||||
| 5 | Sponsors listed in this trial | ||||
| Duke University | |||||
| Aldagen | |||||